IL1B and epilepsy: Furthermore, agmatine also attenuated the increase in NLRP3, ASC, caspase-1, and IL-1β expression and immunocontent in the hippocampus, while reducing IL-1β serum levels in mice submitted to a pentylenetetrazol (PTZ) model of epilepsy [285].